# Prospective Study of the BioVentrix PliCath HF™ System for the Treatment of Ischemic Cardiomyopathy

> **NCT01568138** · NA · COMPLETED · sponsor: **BioVentrix** · enrollment: 26 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** PliCath HF System

## Key facts

- **NCT ID:** NCT01568138
- **Lead sponsor:** BioVentrix
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2021-03-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01568138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01568138, "Prospective Study of the BioVentrix PliCath HF™ System for the Treatment of Ischemic Cardiomyopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01568138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
